Search / Trial NCT00000177

Estrogen Hormone Protocol

Launched by NATIONAL INSTITUTE ON AGING (NIA) · Oct 29, 1999

Apply for Trial

Trial Information

Current as of May 23, 2024

Completed

Keywords

Alzheimer's Disease Estrogen

Description

No description provided

Gender

Female

Eligibility criteria

  • Inclusion Criteria:
  • Women with a diagnosis of Alzheimer's disease who currently are not taking estrogen replacement therapy, who have had a hysterectomy, and who are in stable general health.
  • Exclusion Criteria:
  • Patients with an uncontrolled health problem, such as untreated high blood pressure or thyroid disease.

Attachments

readout_NCT00000177_2024-05-23.pdf

4.5 MB

NCT00000177_study_protocol.pdf

4.5 MB

About company

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Rochester, Minnesota, United States

Baltimore, Maryland, United States

Houston, Texas, United States

Tampa, Florida, United States

Jacksonville, Florida, United States

Atlanta, Georgia, United States

Springfield, Illinois, United States

Kansas City, Kansas, United States

Lexington, Kentucky, United States

Minneapolis, Minnesota, United States

St. Louis, Missouri, United States

New York, New York, United States

Cleveland, Ohio, United States

Philadelphia, Pennsylvania, United States

Pittsburgh, Pennsylvania, United States

Dallas, Texas, United States

Seattle, Washington, United States

Birmingham, Alabama, United States

San Diego, California, United States

Chicago, Illinois, United States

Boston, Massachusetts, United States

White Plains, New York, United States

Indianapolis, Indiana, United States

New York, New York, United States

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Reviews (48)

4.6

All reviews come from applied patients

5 stars
41
4 stars
6
3 stars
2
2 stars
0
1 stars
0
Leslie Alexander
20 September 2023

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Michael Foster
20 September 2023

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Dries Vincent
20 September 2023

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Leslie Alexander
20 September 2023

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Discussion 0